Farmakidis, Constantine
Pasnoor, Mamatha
Barohn, Richard J.
Dimachkie, Mazen M.
Article History
First Online: 21 July 2018
Compliance with Ethical Standards
:
: Constantine Farmakidis has received consultancy fees from Momenta and is an advisory board member of Terumo BCT and Alnylam.Mamatha Pasnoor is a consultant for Momenta and has served on advisory boards for Terumo BCT and Alexion.Richard J. Barohn has received speaker fees from NuFactor, Plan 365 Inc., and Option Care, is on the advisory board of Novaritis Pharmaceuticals, and has received grants from Eli Lilly and Company, PTC Therapeutics, Cytokinetics, Inc., Neuraltus Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., ALSA, MDA-Myotonic Dystrophy Foundation, The Marigold Foundation, Sarepta Therapeutics, IONIS Pharmaceuticals, TEVA Pharmaceuticals, Biomarin, Sanofi/Genzyme, and the NIH.Mazen M. Dimachkie is a consultant or on the speaker’s bureau for Alnylam, Audentes, Biomarin, Catalyst, CSL-Behring, Genzyme, Mallinckrodt, Momenta, Novartis, NuFactor, Octapharma, Sanofi, Shire and Terumo. Dr. Dimachkie received grants from Alexion, Alnylam, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, CSL-Behring, FDA/OPD, GlaxoSmithKline, Genentech, Grifols, MDA, NIH, Novartis, Genzyme, Octapharma, UCB Biopharma, Viromed and TMA.
: This article does not contain any studies with human or animal subjects performed by any of the authors.